glp-1 agonist gastric emptying Agonist-Induced Delayed – A Clinical Pharmacology Perspective glp 1 agonist delayed gastric

[DOI] [PubMed] [Google Scholar] 122.Ahren B, Johnson SL, Stewart M, Cirkel DT, Yang F, Perry C, Feinglos MN HARMONY-3 Study Group

Ahmann, A

Safety Profile and Tolerability Concerns Gastrointestinal Adverse Effects While GLP-1RAs are effective in managing obesity, their use is associated with gastrointestinal side effects and rare but serious adverse events [42] [43] [44]

In arthrofibrosis, osteoarthritis and rheumatoid arthritis, fibrosis of the synovial lining (lining around joints) can occur, creating inflammation, pain and restricted joint mobility [1,7]

There is also the issue of price pressures from both public health systems and private insurers as the GLP-1 class continues to grow and more generic versions are introduced

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review